Reuters logo
BRIEF-Glaxosmithkline says Patrick Vallance to leave as president, research and development
November 8, 2017 / 2:10 PM / 12 days ago

BRIEF-Glaxosmithkline says Patrick Vallance to leave as president, research and development

Nov 8 (Reuters) - Glaxosmithkline Plc

* PATRICK VALLANCE, PRESIDENT, RESEARCH AND DEVELOPMENT, TO LEAVE CO TO BECOME UK GOVERNMENT‘S CHIEF SCIENTIFIC ADVISER AND HEAD OF GOVERNMENT‘S OFFICE FOR SCIENCE​

* ‍APPOINTED DR HAL BARRON AS CHIEF SCIENTIFIC OFFICER AND PRESIDENT, RESEARCH AND DEVELOPMENT, GSK; DR BARRON WILL JOIN GSK ON 1 JANUARY 2018.​

* ‍PATRICK WILL LEAVE GSK AT END OF MARCH 2018 TO TAKE UP HIS NEW ROLE​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below